Publications
Publications 4051 - 4075 de 33557
| Titre | DOI |
|---|---|
|
Baseline characteristics of French patients with wet age-related macular degeneration(wAMD) enrolled in the LUMINOUS study R. Blanco-Garavito; H. Oubraham; B. Wolff; S.Y. Cohen; C.P. Garcher; J.F. Korobelnik; C. Delhay; R. Tadayoni; A. Derveloy; E.H. Souied; F.L.U.M.I.N.O.U.S. Grp 2015 |
|
|
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial S.D. Anker; J. Butler; G. Filippatos; M.Shahzeb Khan; J.Pedro Ferreira; E. Bocchi; M. Bohm; H.Pieter Bru La Rocca; D.J. Choi; V. Chopra; E. Chuquiure; N. Giannetti; J.Esteban Gomez-Mesa; S. Janssens; J.L. Januzzi; J.R. Gonzalez-Juanatey; B. Merkely; S.J. Nicholls; ; I.L. Pina; P. Ponikowski; M. Senni; M.F. Seronde; D. Sim; J. Spinar; I. Squire; S. Taddei; H. Tsutsui; S. Verma; D. Vinereanu; J. Zhang; W. Jamal; S. Schnaidt; J.M. Schnee; M. Brueckmann; S.J. Pocock; F. Zannad; M. Packer; E.M.P.E.R.O.R.P.Trial Comm Inves 2020 |
10.1002/ejhf.2064 |
|
BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 2012-2013 A. Saraux; R.M. Flipo; F. Fagnani; I. Bru; G. Cukierman; J.M. Joubert; W. Czarlewski; J. Dunkel; J. Massol; B. Combe 2015 |
10.1136/annrheumdis-2015-eular.2222 |
|
BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 2012-2013 A. Saraux; R. Flipo; F. Fagnani; I. Bru; G. Cukierman; J. Joubert; W. Czarlewski; J. Dunkel; J. Massol; B. Combe 2015 |
10.1016/j.jval.2015.09.2265 |
|
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies M. Meignan; A.Segolene Cottereau; A. Versari; L. Chartier; J. Dupuis; S. Boussetta; I. Grassi; R.O. Casasnovas; C. Haioun; H. Tilly; V. Tarantino; J. Dubreuil; M. Federico; G. Salles; S. Luminari; J. Trotman 2016 |
10.1200/JCO.2016.66.9440 |
|
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma S. Kanoun; C. Rossi; A. Berriolo-Riedinger; I. Dygai-Cochet; A. Cochet; O. Humbert; M. Toubeau; E. Ferrant; F. Brunotte; R.O. Casasnovas 2014 |
10.1007/s00259-014-2783-x |
|
Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies M. Meignan; A. Versari; A.Segolene Cottereau; L. Chartier; J. Dupuis; S. Boussetta; I. Grassi; R.O. Casasnovas; C. Haioun; H. Tilly; M. Federico; G.A. Salles; S. Luminari; J. Trotman 2015 |
|
|
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity C. Busch; M. Okada; D. Zur; S. Fraser-Bell; P.J. Rodriguez-Valdes; Z. Cebeci; M. Lupidi; A.T. Fung; P.H. Gabrielle; E. Giancipoli; V. Chaikitmongkol; I. Lains; A.Rita Santos; P. Kunavisarut; A. Sala-Puigdollers; J. Chhablani; M. Ozimek; A. Hilely; V. Degenhardt; A. Loewenstein; M. Iglicki; M. Rehak 2020 |
10.1111/aos.14390 |
|
Baseline quality of life (QoL) and chemotherapy related toxicities (CRT) in localized breast cancer (BC) patients (pts): The French multicentric prospective CANTO cohort study I. Licaj; S. Dabakuyo; S. Dauchy; V. Luis; C. Charles; C. Lemogne; O. Tredan; L. Vanlemmens; C. Jouannaud; C. Levy; O. Rigal; M. Fournier; T. Petit; F. Dalenc; P. Rouanet; A. Arnaud; J. Lemonnier; S. Everhard; P.H. Cottu; F. Joly 2019 |
|
|
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma J. Niogret; E. Limagne; M. Thibaudin; J. Blanc; A. Bertaut; K. Le Malicot; Y. Rinaldi; F.X. Caroli-Bosc; F. Audemar; S. Nguyen; C. Sarda; C. Lombard-Bohas; C. Locher; M. Carreiro; J.L. Legoux; P.L. Etienne; M. Baconnier; M. Porneuf; T. Aparicio; F. Ghiringhelli 2020 |
10.3390/cancers12061429 |
|
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma C. Rossi; M. Tosolini; P. Gravelle; S. Pericart; S. Kanoun; S. Evrard; J. Gilhodes; D.M. Franchini; N. Amara; C. Syrykh; P. Bories; L. Oberic; L. Ysebaert; L. Martin; S. Ramla; P. Robert; C. Tabouret-Viaud; R.O. Casasnovas; J.J. Fournie; C. Bezombes; C. Laurent 2022 |
10.3324/haematol.2020.263194 |
|
Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma A.S. Cottereau; S. Hapdey; L. Chartier; R. Modzelewski; O. Casasnovas; E. Itti; H. Tilly; P. Vera; M.A. Meignan; S. Becker 2017 |
10.2967/jnumed.116.180406 |
|
Baseline Total Metabolic Tumour Volume measured with fixed or different adaptive thresholding methods equally predicts outcome in Peripheral T cell lymphoma. A.Segolene Cottereau; S. Hapdey; R. Modzelewski; I. Gardin; E. Itti; O. Casasnovas; H.A. Tilly; P. Vera; M. Meignan; S. Becker 2016 |
|
|
Baseline Total Metabolic Tumour Volume measured with fixed or different adaptive thresholding methods equally predicts outcome in Peripheral T cell lymphoma. A.Segolene Cottereau; S. Hapdey; R. Modzelewski; I. Gardin; E. Itti; O. Casasnovas; H.A. Tilly; P. Vera; M. Meignan; S. Becker 2016 |
|
|
BASELINE TOTAL METABOLIC VOLUME (TMTV) PREDICTS THE OUTCOME OF PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (HL) ENROLLED IN THE AHL2011 LYSA TRIAL O. Casasnovas; S. Kanoun; I. Tal; A.S. Cottereau; V. Edeline; P. Brice; R. Bouabdallah; G. Salles; A. Stamatoullas; J. Dupuis; O. Reman; T. Gastinne; B. Joly; K. Bouabdallah; E. Nicolas-Virelizier; M. Andre; N. Mounier; C. Ferme; M. Meignan; A. Berriolo-Riedinger 2016 |
|
|
BASELINE TOTAL METABOLIC VOLUME (TMTV) PREDICTS THE OUTCOME OF PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (HL) ENROLLED IN THE AHL2011 LYSA TRIAL O. Casasnovas; S. Kanoun; I. Tal; A.S. Cottereau; V. Edeline; P. Brice; R. Bouabdallah; G. Salles; A. Stamatoullas; J. Dupuis; O. Reman; T. Gastinne; B. Joly; K. Bouabdallah; E. Nicolas-Virelizier; M. Andre; N. Mounier; C. Ferme; M. Meignan; A. Berriolo-Riedinger 2016 |
|
|
Baseline tumor volume affects rituximab pharmacokinetics in patients with diffuse large B-cell lymphoma (DLBCL) M. Tout; G. Cartron; O. Casasnovas; M. Meignan; G. Paintaud; D. Ternant 2015 |
|
|
Baseline tumor volume affects rituximab pharmacokinetics in patients with diffuse large B-cell lymphoma (DLBCL) M. Tout; G. Cartron; O. Casasnovas; M. Meignan; G. Paintaud; D. Ternant 2015 |
|
|
Baseline-derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) to predict the benefit of immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients. L. Mezquita; E. Auclin; R. Ferrara; C. Audigier-Valette; L. Tessonnier; M. Charrier; M.Eve Boucher; J. Lahmar; C. Caramella; J. Remon; D. Planchard; J. Adam; A. Gazzah; N. Chaput; J.C. Soria; B. Besse 2017 |
10.1200/JCO.2017.35.15_suppl.9089 |
|
Basic mechanisms in the laser control of non-Markovian dynamics R. Puthumpally-Joseph; E. Mangaud; V. Chevet; M. Desouter-Lecomte; D. Sugny; O. Atabek 2018 |
10.1103/PhysRevA.97.033411 |
|
Basic modeling of the visco elastic behavior of flax fiber composites C. Stochioiu; B. Piezel; A. Chettah; S. Fontaine; H.M. Gheorghiu 2019 |
10.35530/IT.070.04.1512 |
|
Basic theory of solvable Lie algebras and Lie groups D. Arnal; B. Currey 2020 |
|
|
Bateman purpura (dermatoporosis): a localized scurvy treated by topical vitamin C - double-blind randomized placebo-controlled clinical trial P. Humbert; F. Fanian; T. Lihoreau; A. Jeudy; G.E. Pierard 2018 |
10.1111/jdv.14525 |
|
Bathymetric variation of epiphytic assemblages on Posidonia oceanica (L.) Delile leaves in relation to anthropogenic disturbance in the southeastern Mediterranean M. Ben Brahim; L. Mabrouk; A. Hamza; M. Mahfoudi; A. Bouain; L. Aleya 2014 |
10.1007/s11356-014-3315-8 |
|
Battery aging study using field use data L. Vichard; A. Ravey; S. Morando; F. Harel; P. Venet; S. Pelissier; D. Hissel 2017 |